NasdaqGS - Nasdaq Real Time Price USD
Inozyme Pharma, Inc. (INZY)
0.9810
-0.0490
(-4.76%)
As of 1:05:21 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-91,907
-91,907
-70,675
-57,761
-48,153
Investing Cash Flow
66,998
66,998
-53,646
-5,403
42,796
Financing Cash Flow
11,398
11,398
125,969
72,788
609
End Cash Position
21,392
21,392
34,899
33,269
23,670
Interest Paid Supplemental Data
4,350
4,350
2,347
170
--
Capital Expenditure
-62
-62
-298
-410
-397
Issuance of Capital Stock
10,521
10,521
85,647
56,137
--
Issuance of Debt
--
--
40,000
4,050
--
Free Cash Flow
-91,969
-91,969
-70,973
-58,171
-48,550
12/31/2021 - 7/24/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TNGX Tango Therapeutics, Inc.
1.5000
+0.67%
TCRX TScan Therapeutics, Inc.
1.6000
+1.91%
CMMB Chemomab Therapeutics Ltd.
1.2300
+5.13%
LRMR Larimar Therapeutics, Inc.
2.2400
-5.88%
DSGN Design Therapeutics, Inc.
4.0500
+2.27%
VTYX Ventyx Biosciences, Inc.
1.1700
-0.85%
SWTX SpringWorks Therapeutics, Inc.
40.87
+0.91%
URGN UroGen Pharma Ltd.
10.19
+1.39%
GBIO Generation Bio Co.
0.4180
+2.08%
ORIC ORIC Pharmaceuticals, Inc.
5.35
+2.49%